Medical Claims International SL’s Post

Discover how adopting advanced technologies, ethical #leadership, and regulatory adaptability can help #hospitals stay ahead of #compliance challenges and enhance patient care. Read part 2 of our blog series! 

How Can You Navigate Complex Ethical Decisions in Healthcare? -https://lnkd.in/gskCtkPC #MedicalDirector Article via Featured, an expert insights platform

🌟 Ever wondered about doctors treating themselves? While it sounds empowering, medical ethics steer us away from self-diagnosis and treatment. Objectivity is key in healthcare, urging healthcare professionals to seek care from trusted colleagues for the best outcomes. It's important to note that self-treatment by doctors is generally discouraged in medical practice. #MedicalEthics #HealthcareExcellence #DoctorsCare #CollaborativeMedicine

A big thank you to all who attended the Association of Corporate Counsel Australia event last night to launch the Health Law Network (HLN). It was a great turn out despite the terrible weather. Thanks also to Shaun Larkin, Kevin Barrow, Jennifer Mulheron and Toby Patten for an engaging discussion. Deeply appreciate Baker McKenzie for hosting and moderating the discussion. We value your feedback, so please follow the survey link sent to attendees. Finally, do reach out with any topic ideas for future sessions. Key take outs from the session: ✍️ We need to treat patients wholeistically and as part of local community solutions rather than merely applying medical solutions. ✍️ We need to encourage connectivity between data sets to breakdown silos between clinics to support patient journeys. ✍️ We need to examine treatment flows in order to eliminate inefficiencies and fill gaps in care with appropriate resourcing, moving away from fee for service models. ✍️ We should consider how to incentivise health practitioners and patients to adopt data transferability and new technologies possibly leveraging existing funding models. ✍️ We should be looking at regulations pertaining to AI, Software as a Medical Device, and Privacy with the aim of building trust in compliance and security encouraging uptake. ✍️ We should encourage development and uptake of AI in diagnostics and other areas supporting local innovation through funding with a positive and pragmatic mindset with respect to risk.

Happy to share my newest interview with Medical Ethics Advisor about advance care planning and the importance of designating an MPOA you trust to effectuate your wishes, even if they disagree: https://lnkd.in/gJ9PxH3Y

“Compliance in the medical device industry is the cornerstone of innovation in healthcare, ensuring that every breakthrough not only enhances patient outcomes but also upholds the highest standards of safety, ethics, and trust.”

💡 Insights into the Acceptability of eConsent from a Global, Ethical, and Industry Perspective by the EFGCP - European Forum for Good Clinical Practice eConsent initiative! The strong focus on compliance and patient-centricity by Sonsors confirms our mission to shaping a new standard for data integrity so that trust turns into value and improved patient care! Link to article: https://lnkd.in/g9jfSyeB

HOT OFF THE PRESSES! In a new article, Institute Faculty Director Bill Sage and Executive Director Keegan Warren, J.D., LL.M. argue that the value of lawyers as onsite healthcare practitioners might be more prominent through attention to aligning the medical-legal partnership (#MLP) model with traditional medical care financing and delivery. Following a brief description of the professional resonance between MLP and the established medical sector, they explore three themes: the way professionals move (clinical alignment); the way data move (informational alignment); and the way money moves (payment alignment). https://lnkd.in/dEKQfXTS

𝐓𝐫𝐚𝐧𝐬𝐩𝐚𝐫𝐞𝐧𝐜𝐲 𝐢𝐧 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐓𝐫𝐢𝐚𝐥𝐬: 𝐓𝐡𝐞 𝐑𝐨𝐥𝐞 𝐨𝐟 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐏𝐫𝐨𝐟𝐞𝐬𝐬𝐢𝐨𝐧𝐚𝐥𝐬 #Transparency is not just a buzzword – it's an essential foundation for trust, credibility, and ethical conduct. As dedicated professionals in the industry, we play a pivotal role in ensuring that transparency remains at the core of every clinical trial. 𝐖𝐡𝐲 𝐓𝐫𝐚𝐧𝐬𝐩𝐚𝐫𝐞𝐧𝐜𝐲 𝐌𝐚𝐭𝐭𝐞𝐫𝐬: Transparency goes beyond mere compliance with regulations; it involves open communication, honesty, and accountability throughout the research process. 𝐇𝐞𝐫𝐞'𝐬 𝐰𝐡𝐲 𝐢𝐭 𝐦𝐚𝐭𝐭𝐞𝐫𝐬: 𝐏𝐚𝐭𝐢𝐞𝐧𝐭 𝐓𝐫𝐮𝐬𝐭: Transparent practices instill confidence in participants, fostering a positive experience and encouraging their active involvement. 𝐒𝐜𝐢𝐞𝐧𝐭𝐢𝐟𝐢𝐜 𝐈𝐧𝐭𝐞𝐠𝐫𝐢𝐭𝐲: Transparent reporting of results ensures the accuracy and validity of data, leading to evidence-based decision-making. 𝐒𝐚𝐟𝐞𝐭𝐲 𝐚𝐧𝐝 𝐄𝐭𝐡𝐢𝐜𝐬: Transparent disclosure of potential risks and benefits helps safeguard the well-being of participants, ensuring ethical research standards are upheld. 𝐑𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲 𝐂𝐨𝐦𝐩𝐥𝐢𝐚𝐧𝐜𝐞:Transparent practices are critical in meeting regulatory requirements, gaining approvals, and maintaining a good standing with authorities. As stakeholders in the clinical research process, we have a shared responsibility to promote transparency at every stage. Here's how we can #makeadifference 𝐈𝐧𝐟𝐨𝐫𝐦𝐞𝐝 𝐂𝐨𝐧𝐬𝐞𝐧𝐭: Ensuring that participants fully understand the study's purpose, risks, and their rights is paramount to obtaining valid informed consent. 𝐑𝐞𝐬𝐮𝐥𝐭𝐬 𝐑𝐞𝐩𝐨𝐫𝐭𝐢𝐧𝐠: Transparently sharing all study results, whether positive or negative, avoids publication bias and contributes to scientific knowledge. 𝐃𝐚𝐭𝐚 𝐒𝐡𝐚𝐫𝐢𝐧𝐠: Advocating for responsible data sharing practices allows for external validation, scrutiny, and the advancement of research in the broader scientific community. 𝐂𝐨𝐧𝐟𝐥𝐢𝐜𝐭 𝐨𝐟 𝐈𝐧𝐭𝐞𝐫𝐞𝐬𝐭 𝐃𝐢𝐬𝐜𝐥𝐨𝐬𝐮𝐫𝐞: Being transparent about potential conflicts of interest helps maintain research integrity and credibility. 𝐄𝐧𝐠𝐚𝐠𝐢𝐧𝐠 𝐰𝐢𝐭𝐡 𝐏𝐚𝐫𝐭𝐢𝐜𝐢𝐩𝐚𝐧𝐭𝐬: Cultivating open lines of communication with participants and addressing their concerns with honesty fosters trust and encourages ongoing engagement.   #ClinicalResearch #TransparencyMatters #ResearchIntegrity #PatientCentricity #EthicalResearch #DataSharing #HealthcareEthics #PatientTrust #ScienceMatters #Integrity #Informedconsent

Siow Ching Yee vs Columbia Asia Medicolegal Forum Register now.. Title: Exploring the Siow Ching Yee vs Columbia Asia Landmark Trial: Implications for Healthcare Practices Date: April 3, 2024, Wednesday Time: 9:00 PM Duration: 1 to 1.5 hours Introduction: The Siow Ching Yee vs Columbia Asia case stands as a pivotal moment in medicolegal history, shaping the landscape of healthcare practices and patient rights. This forum brings together esteemed panelists to delve into the intricacies of this landmark trial, its implications on medical ethics, and the broader implications for healthcare providers. Panelists: Mr. Manmohan Dhillon, Partner of PS Ranjan Datuk Dr. Kuljit Singh, President of the Association of Private Hospitals of Malaysia Mr. Japhire Gopi Kannan, Founder and CEO of Doctorshield Agenda: 1. Case Overview: Brief summary of the Siow Ching Yee vs Columbia Asia case, highlighting key events, legal arguments, and the final verdict. 2. Medical Ethics and Standards: Discussion on the ethical considerations raised by the case, including issues of patient consent, standard of care, and professional accountability. 3. Legal Implications: Analysis of the legal precedents set by the trial and its impact on future medicolegal cases in Malaysia and beyond. 4. Patient Rights and Advocacy: Examination of the case's influence on patient rights awareness, empowerment, and the role of advocacy in healthcare. 5. Healthcare Provider Perspectives: Insights from healthcare providers on how the case has influenced their practices, patient interactions, and risk management strategies. 6. Q&A Session: Audience engagement session, allowing participants to seek clarification, share insights, and discuss implications for their own practices. Conclusion: The Siow Ching Yee vs Columbia Asia case serves as a poignant reminder of the complex interplay between medicine, law, and ethics in healthcare. This forum aims to deepen our understanding of these dynamics and foster a dialogue that promotes ethical, patient-centered care.